Pathogenesis of Aleutian mink disease parvovirus and similarities to B19 infection

被引:17
|
作者
Best, SM [1 ]
Bloom, ME [1 ]
机构
[1] NIAID, Persistent Viral Dis Lab, NIH, Rocky Mt Labs, Hamilton, MT 59840 USA
关键词
D O I
10.1111/j.1439-0450.2005.00864.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Aleutian mink disease parvovirus (ADV) is an unusual member of the autonomous parvoviruses in both its replication and pathogenesis. Infection of newborn mink kits results in an acute disease typified by virus replication in type II pneumocytes in the lung. This replication is permissive and cytopathic, characterized by the production of high levels of viral replicative intermediates and infectious progeny. However, infection of adult Aleutian mink leads to a chronic form of the disease termed Aleutian disease (AD). In this case, virus replication occurs predominantly in lymph node macrophages and is restricted, with viral DNA replication, RNA transcription, protein expression and production of infectious progeny occurring at low levels. B19 is the only autonomous parvovirus known to infect humans. The primary site of virus replication in both children and adults is in erythrocyte precursors in the blood and bone marrow, although viral genomes have been detected in various other tissues. B19 infection often causes a self-limiting disease although persistent infection of B19 can occur in both immuno-compromised and -competent people. Perhaps the most striking similarity between infection with ADV or with B19 is the important role the humoral immune response to infection has in pathogenesis. It can be both protective and pathogenic. Due to of the central role of antibody in the disease caused by either virus, understanding the specific roles of antibody production in protection, antibody-mediated enhancement of infection, the establishment of persistent infection and immune-mediated pathology will provide insight into the pathogenesis of these infections. A second similarity between the two viruses is the ability to establish persistent infection. Persistence of ADV is associated with restricted replication. Although many cellular factors may contribute to restricted virus replication, the interactions between the major non-structural protein, NS1, and the cells are likely to be critical. Parallels exist between the expression and post-translational modification of ADV and B19 NS1 proteins that may contribute to restriction of virus replication. Thus, a study of the regulation of NS1 expression and its interactions with cell signalling pathways may lead to increased understanding of the restricted replication of these two viruses, and perhaps of persistent infection.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 50 条
  • [31] LABORATORY INFECTION WITH PARVOVIRUS B19
    COHEN, BJ
    COUROUCE, AM
    SCHWARZ, TF
    OKOCHI, K
    KURTZMAN, GJ
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (09) : 1027 - 1028
  • [32] Parvovirus B19 infection and pregnancy
    Subtil, Damien
    Garabedian, Charles
    Chauvet, Agathe
    PRESSE MEDICALE, 2015, 44 (06): : 647 - 653
  • [33] HUMAN PARVOVIRUS B19 INFECTION IN KAWASAKI-DISEASE
    YOTO, Y
    KUDOH, T
    HASEYAMA, K
    SUZUKI, N
    CHIBA, S
    MATSUNAGA, Y
    LANCET, 1994, 344 (8914): : 58 - 59
  • [34] Cutaneous parvovirus B19 infection associated with bowel disease
    Gonzalez-Sabin, Marta
    De-Andres-Del-Rosario, Ana
    Garcia-Martin, Carlos
    Rosende-Maceiras, Laura
    Almagro-Sanchez, Manuel
    Iglesias-Conde, Raquel
    Nespereira-Jato, Victoria
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB133 - AB133
  • [35] Digital arterial occlusive disease and parvovirus B19 infection
    Kern, P
    VASA-JOURNAL OF VASCULAR DISEASES, 2002, 31 (04): : 274 - 275
  • [36] IS STILLS DISEASE-ASSOCIATED WITH PARVOVIRUS B19 INFECTION
    GODEAU, B
    PALAZZO, E
    MORINET, F
    DEPLANCHE, M
    DEFORGE, L
    SCHAEFFER, A
    KAHN, MF
    LANCET, 1995, 345 (8941): : 59 - 60
  • [37] KAWASAKI-DISEASE ASSOCIATED WITH PARVOVIRUS B19 INFECTION
    HOLM, JM
    HANSEN, LK
    OXHOJ, H
    EUROPEAN JOURNAL OF PEDIATRICS, 1995, 154 (08) : 633 - 634
  • [38] ALEUTIAN DISEASE VIRUS, A PARVOVIRUS, IS PROTEOLYTICALLY DEGRADED DURING INVIVO INFECTION IN MINK
    AASTED, B
    RACE, RE
    BLOOM, ME
    JOURNAL OF VIROLOGY, 1984, 51 (01) : 7 - 13
  • [39] PATHOGENESIS AND CONTROL OF ALEUTIAN DISEASE OF MINK
    INGRAM, DG
    AN, SH
    DEPAULI, F
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 1976, 67 (02): : 128 - 128
  • [40] PARVOVIRUS B19 FINDS A DISEASE
    COSSART, Y
    LANCET, 1981, 2 (8253): : 989 - 989